Sort
85,873 grants matching “alzheimers”
Development and Validation of the EMR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR)
$793,100Deborah E. Barnes · Northern California Institute/Res/Edu · R56 · FY2017 · AG
Age-related Hypertension and Vascular Cognitive Impairment
$793,084Richard David Wainford · Emory University · R01 · FY2024 · AG
Perceived racism, cardiovascular disease risk, and neurocognitive aging
$793,077Karin Schon · Boston University Medical Campus · R01 · FY2023 · AG
Salivary Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Related Disorders
$793,072Jill Kreiling · Brown University · R01 · FY2023 · AG
CLINICAL CORE
$793,017Richard J. Caselli · Banner Sun Health Research Institute · P30 · FY2007 · AG
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study
$793,009Jennifer Louise Whitwell · Mayo Clinic Rochester · R01 · FY2023 · AG
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study
$793,009Jennifer Louise Whitwell · Mayo Clinic Rochester · R01 · FY2022 · AG
Hypertension, Blood Pressure Targets, and Alzheimerâs Disease and Dementia Risk and Disparities among Nationally Representative US Veterans
$792,967Kristine Yaffe · University Of California, San Francisco · R01 · FY2025 · AG
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
$792,934Julia Tcw · Boston University Medical Campus · R01 · FY2023 · AG
Protecting the Confidentiality of Participants in Studies of Alzheimer's Disease and Related Dementias by Replacing Face Imagery in MRI
$792,903Christopher George Schwarz · Mayo Clinic Rochester · R01 · FY2023 · AG
Protecting the Confidentiality of Participants in Studies of Alzheimer's Disease and Related Dementias by Replacing Face Imagery in MRI
$792,903Christopher George Schwarz · Mayo Clinic Rochester · R01 · FY2024 · AG
Molecular and structural imaging in atypical Alzheimer's disease: a longitudinal study
$792,891Jennifer Louise Whitwell · Mayo Clinic Rochester · R01 · FY2024 · AG
Amyloid-Beta and Tau/Glycosaminoglycan Dual Inhibitor for Alzheimer's Disease
$792,857Paul Gregor · Gismo Therapeutics, Inc. · R44 · FY2023 · AG
Vitamin B12 status, cognitive decline and incident dementia
$792,825Paul F Jacques · Tufts University Boston · R01 · FY2019 · AG
Dual-Task Training Exercise to Reduce Falls in Older Adults with Mild Cognitive Impairment
$792,805Fuzhong Li · Oregon Research Institute · R01 · FY2023 · AG
Protecting the Confidentiality of Participants in Studies of Alzheimer's Disease and Related Dementias by Replacing Face Imagery in MRI
$792,752Christopher George Schwarz · Mayo Clinic Rochester · R56 · FY2020 · AG
Core C: Data Management and Statistics Core
$792,750Karen J. Bandeen-Roche · Johns Hopkins University · P30 · FY2022 · AG
LRP1-tau interactions and Alzheimer Disease
$792,690Dudley K. Strickland · University Of Maryland Baltimore · R01 · FY2024 · AG
Daily Experiences and Well-being among Caregivers for Older Adults Experiencing Lewy Body Dementia.
$792,683Karen L Fingerman · University Of Texas At Austin · R01 · FY2024 · AG
Administrative Core
$792,656Scott A Small · Columbia University Health Sciences · P30 · FY2020 · AG
Non-invasive optical imaging of neuropathology in vivo
$792,619Brian J Bacskai · Massachusetts General Hospital · R01 · FY2007 · AG
p53, Aging, and Cancer
$792,614Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Rehabilitation and Prophylaxis of Anomia in Primary Progressive Aphasia
$792,600Rhonda B Friedman · Georgetown University · R01 · FY2017 · DC
The Use of Rhythmic Light Therapy to Entrain Gamma Oscillations and the Circadian System in Patients with Alzheimer's Disease and Related Dementias (ADRD)
$792,504Mariana Gross Figueiro · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
A knowledge map to find Alzheimer's disease drugs
$792,498Olivier Lichtarge · Baylor College Of Medicine · R01 · FY2020 · AG